Bayesian Capital Management, LP Amarin Corp Plcuk Transaction History

Bayesian Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $22,440 - $30,940	34,000 New	34,000 $29,000
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $21,356 - $69,741	-18,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $53,865 - $70,497	18,900 New	18,900 $62,000
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $155,428 - $331,352	-42,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $204,106 - $352,702	42,700 New	42,700 $295,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $40,400 - $217,453	-10,100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $124,066 - $214,668	-8,900 Reduced 46.84%	10,100 $217,000
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $263,910 - $440,040	19,000 New	19,000 $288,000
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $430,001 - $761,453	-34,100 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $423,181 - $783,618	34,100 New	34,100 $464,000
Q4 2017 Feb 12, 2018	SELL	$3.06 - $4.09 $60,894 - $81,391	-19,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $60,296 - $74,028	19,900	19,900 $70,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.